• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) Inspira Smooth Silicone Gel Filled Breast Implant; prosthesis, breast, noninflatable, internal, silicone gel-filled

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) Inspira Smooth Silicone Gel Filled Breast Implant; prosthesis, breast, noninflatable, internal, silicone gel-filled Back to Search Results
Catalog Number SSF-240
Medical Device Problem Code Device Appears to Trigger Rejection (1524)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 10/07/2024
Type of Reportable Event Serious Injury
Event or Problem Description
Healthcare professional reported "right side capsular contracture, baker grade iv," the device remains implanted.
 
Additional Manufacturer Narrative
The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture baker grade iv.A review of the device history record has been completed.No deviations or non-conformances noted.
 
Event or Problem Description
Healthcare professional reported "right side capsular contracture, baker grade iv," the device was explanted.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: b5, d6b, h.6.
 
Event or Problem Description
Healthcare professional reported "right side capsular contracture, baker grade iv," the device was explanted.
 
Event or Problem Description
Healthcare professional reported "right side capsular contracture, baker grade iv," the device was explanted.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: h11.Fi summary: the review of the documentation associated to the manufacturing process indicates that all devices involved in this work order were released in accordance with abbvie¿s procedures and were no defects/problems/issues found in the documents or in the personnel training related to the reported event.Additionally, no er/ ncr(s) were identified during the investigation associated with this lot and the complaint.According to the device analysis performed in the laboratory was observed a split (ss) in patch area, it is out of specification per qa 199.04.The event of capsular contracture was unable to observed, and the workmanship has not relation to reported complaint.Therefore, the reported events was not confirmed.A review of the current risk documents pfmea-silicone filled bi and sizer assembly, smooth rev 3.0 was performed, and the event of split in patch is a known event, for which current process controls and inspections are established to reduce the incidence of this defect.Considering that there is no adverse trend for this type of event, no additional actions are deemed required at this time.The issue with split in patch will continue to be monitored and corrective actions will be taken in the future if deemed appropriate.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: d9, h3, h6.Device evaluation: per the analysis performed, the assessments of the complaints and any potential manufacturing issue are displayed along with any further actions required: ¿ capsular contracture: unable to observe through visual inspection as it is a physiological phenomenon.A workmanship was observed through visual inspection not related to the complaint for a observed split in patch area event.A further investigation is requested.None of the other observations performed during the device analysis deformation and creases are found to be potentially related to the manufacturing process, and, therefore, no further actions are required for these observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Inspira Smooth Silicone Gel Filled Breast Implant
Common Device Name
prosthesis, breast, noninflatable, internal, silicone gel-filled
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
la aurora de heredia
CS 
Manufacturer (Section G)
Allergan (Costa Rica)
900 parkway global park
zona franca
la aurora de heredia
CS  
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
+1(847)936-6324
MDR Report Key20812310
Report Number9617229-2024-25253
Device Sequence Number21317313
Product Code FTR
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 08/27/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberSSF-240
Device Lot Number1212382
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/01/2026
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/12/2024
Supplement Date Received by Manufacturer04/28/2026
07/17/2026
08/10/2026
Initial Report FDA Received Date11/29/2024
Supplement Report FDA Received Date05/26/2026
08/06/2026
08/27/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/24/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age35 YR
Patient SexFemale
Patient Weight130 LB
-
-